Age, period, and cohort effects - Influences on differences between cross-sectional and longitudinal pulmonary function results
Age, period, and cohort effects - Influences on differences between cross-sectional and longitudinal pulmonary function results
复制标题
DOI:
10.1164/ajrccm/154.6_pt_2.s273
复制
发表时间:
1996-12-01
影响因子:
24.7
通讯作者:
Lebowitz, MD
中科院分区:
文献类型:
--
作者:
Lebowitz, MD
METHODSDifferences/discrepancies will be examined first between cross-sectional results of lung function relationships with age (and body habitus) at different periods and between cross-sectional and longitudinal results in the same population. The Tucson Longitudinal Study of AOD will be utilized for these analyses (1-12, 24, 25). The overall objectives of the Tucson Study of AOD include: the physiologic characterization of growth and decline of function, an improved understanding of the role of smoking, determination of the long-term effects of childhood respiratory troubles, studies of the impacts of environmental/occupational exposures and social factors, and better prediction of AOD. The study utilizes a multistage, stratified cluster sample of about 3,800 non-Mexican American whites (" Anglo") described previously (5, 24). Since enrollment (1972-73), newborns and marital partners in the families have been enrolled, bringing the total enrolled to about 5,600. The evaluations during every survey included standard respiratory symptom and other questionnaires (5, 24) and standard maximal expiratory flowvolume (MEFV) curves (2, 3, 9, 11, 25, 26). The longitudinal status of the Anglo subjects has beenpresented previously (5); they are still considered representative of the Tucson population. As expected, deaths occurred preferentially in older ages, males, smokers, and those with diagnosed AOD. Within participants, the proportion of males, and the average age within each gender did not differ significantly by survey. However, the proportions of current smokers decreased and of ex-smokers increased over time.Most of these comparisons will be performed utilizing the" healthy" subjects (asymptomatic never smokers)(2, 9, 25). We have evaluated the influence of initial lung function as a determinant of the longitudinal rate of change in lung function and of survivorship on the differences observed. Body habitus and some of the risk factors also will be used to evaluate the possible differences. Symptoms as predictors and as endpoints will be looked at secondarily to the evaluation of lung function itself (1, 4, 5, 8, 9, 12). The potential benefit of comparing those findings to results in other populations and periods will be appraised. Potential effects of frequency of evaluation, measurement errors, sources of variation, and regression-to-the-mean will be examined, and the methodologic approaches as potential bases for differences will be evaluated (2, 4, 6-9, 12, IS, 19, 20, 25-30).